Table 2 Clinical characteristics related to miR-632
From: miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner
Characteristics | miR-632 | Positive rate (%) | P value | |
|---|---|---|---|---|
Positive | Negative | |||
Gender | ||||
 Male | 22 | 5 | 81.48 | 0.114 |
 Female | 8 | 7 | 53.33 | |
Age (yr) | ||||
 60 yr. or younger | 13 | 6 | 68.42 | 0.695 |
 Over 60 yr | 17 | 6 | 73.91 | |
Differentiation | ||||
 Moderate | 21 | 8 | 72.41 | 1.000 |
 Poor | 9 | 4 | 69.23 | |
Stage | ||||
 I + II | 27 | 7 | 79.41 | 0.054 |
 III + IV | 3 | 5 | 37.50 | |
Lymph nodes involvement | ||||
 Yes | 3 | 3 | 50.00 | 0.443 |
 No | 27 | 9 | 75.00 | |